Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)

Overview of attention for article published in Oncologist, April 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 1 X post from an account with 25,848 followers.

Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR) #PhaseII #TRAXAR #Axitinib #RenalCellCancer #RCC #Endoglin #TRC105 #Carotuximab https://t.co/PYI…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.